WHO has allowed Gavi and Unicef to procure mpox vaccines ahead of its formal approval to quickly deliver them to Africa amidst a growing outbreak. Vaccines by Bavarian Nordic and KM Biologics, already approved in the U.S. and Japan, are anticipated to receive WHO emergency approval in September to speed up distribution.
